GBA's "2021 Stock Phantasma"

stonedinvestor said:
Hey Van did you know Japanese company is involved with ABB on those mini nuclear reactors.-!
They're everywhere... these Japanese companies...

Fluor says IHI is investing $20M in NuScale Power 05/26 FLR Fluor announced that IHI Corporation of Japan is investing $20M into NuScale Power, a small modular nuclear reactor technology company in which Fluor is the majority investor. IHI's immediate investment of $20M may be followed by another $20M later, the company said. In addition to IHI's ownership interest, IHI will become a manufacturing partner and have the opportunity to provide design services and heavy manufacturing of the steel plate reinforced concrete wall structures for NuScale SMR projects in which Fluor has the lead role, it added.

NuScale Power SPAC-?
More...
Seeeee. You never read my posts. That's why I have to bash your stocks, to get you to pay attention.

vanzandt said:
Remember what I said earlier about nuclear power?
Japan is building small modular nuclear plants.
We'll be needing those too.
And you know they must be safe, I'm sure Japan is pretty tight on that now after Fukishima.
Fluor leading the way.

.
More...
 
vanzandt said:
Seeeee. You never read my posts. That's why I have to bash your stocks, to get you to pay attention.
More...


No I read it but the name of the Japanese company! That I found.
IHI Corporation (IHICY) Seems to trade in 1 hr movements
Other OTC - Other OTC Delayed Price. Currency in USD

$5.650.00 (0.00%)
As of July 7 9:40AM
 
The Next Frontier in Bio is probably psychedelic -

Psychedelic drug developers started as buys
  • Citi, Credit Suisse, Canaccord Genuity, and Cantor Fitzgerald have initiated Atai Life Sciences (ATAI +2.3%) with buy/overweight ratings.
  • Credit Suisse has a $25 price target on shares (~35% upside)
  • Credit Suisse analyst Judah Frommer says the company has developed 10 development programs and six enabling technologies covering areas such as depression, anxiety, and post-traumatic stress disorder. Five of those programs center around psychedelic compounds.
  • Although development of psychedelics for mental health conditions is in its infancy, "we believe significant unmet need could drive a paradigm shift in how mental health disorders are treated in the next ~10 years," he says.
  • Citi's Neena Bitritto-Garg writes that emerging data on the clinical benefit of psychedelics and increasing regulatory flexibility is a boon to companies like Atai.
  • Citi surveyed 108 psychiatrists and most said they would be eager to prescribe psychedelic prescription medications in a meaningful way.
  • Bitritto-Garg also initiated psychedelics player COMPASS Pathways (CMPS +2.4%) with a buy.
ATAI--
 
stonedinvestor said:
No I read it but the name of the Japanese company! That I found.
IHI Corporation (IHICY) Seems to trade in 1 hr movements
Other OTC - Other OTC Delayed Price. Currency in USD

$5.650.00 (0.00%)
As of July 7 9:40AM
More...
What do you think about AZEK down here at $38?
It's at that H&S cusp on a 1 year chart.
Earnings should be the 2nd week of August, but they have not given out a date yet, I don't think.

CEO has been selling shares.
That's bs imo.
He gets on Cramer and says what a great company it is.
Then why sell your shares?
Your salary is quite adequate to have a 3 million dollar plus estate and a few toys...
 
Yea AZEK CEO is a putz. The future is great I'm selling.

These guys are a few bucks beneath a secondary they did I believe at $43.50!

Those folks got lied to. And then he sold. They cannot be happy. So when this gets back to $43.50 they just say bye bye. This stock is now in WEAK HANDS,,,

I still think Weak Hands/Strong Hands is a great idea for a thread and an investing style.
 
You must log in or register to reply here.
Back
Top